Cardlytics Inc (CDLX) is a publicly traded advertising agencies business based in the US. On 22 May Cardlytics shares leapt 12.65% to a closing position of $5.7. Over the last 12 months, Cardlytics's share price has risen by a staggering 346.15% from $27.67. Cardlytics is listed on the NASDAQ and employs 489 staff. All prices are listed in US Dollars.
How to buy shares in Cardlytics
Choose a platform.If you're a beginner, our share-dealing table below can help you choose.
Open your account.You'll need your ID, bank details and national insurance number.
Confirm your payment details.You'll need to fund your account with a bank transfer, debit card or credit card.
Search the platform for stock code:CDLX in this case.
Research Cardlytics shares.The platform should provide the latest information available.
Buy your Cardlytics shares.It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy Cardlytics shares:
Best for
0% commission
Best for
Beginners
Best for
Beginner investments
BEST FOR
Transfer bonus
To choose the best investment app for each category, our experts analysed 83 different metrics for the investment platforms we've reviewed on our site. We've hand-picked the metrics we think are important for each category to help us find the best in 17 categories among our high-scoring partners. There are also "promoted" picks on some pages. They're based on factors that include special features or offers and the commission we receive. It's important to compare the full range of platforms available and keep in mind our picks may not always be the best fit for you.
Fees for buying 5x Cardlytics shares with popular platforms
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Alternative ways to invest in Cardlytics
Buying shares in just one company can leave you more exposed to unexpected swings in the market than if you have a range of investments - a "diversified portfolio". Experts generally recommend having a broad mix of assets and funds that hold a ready-made portfolio of at least 50 different companies' shares, on the basis that drops in the value of some will be offset by rises elsewhere.
Cardlytics is a major part of the NASDAQ index, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Is it a good time to buy Cardlytics stock?
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Use our graph to track the performance of CDLX stocks over time.
Share price volatility
Over the last 12 months, Cardlytics's shares have ranged in value from as little as $2.57 up to $29.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cardlytics's is 1.759. This would suggest that Cardlytics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Historical closes compared with the last close of $123.45
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Sign up for expert share trading insights
Join 50,000 subscribers who are notified about expert money tips. Plus a chance to win £500!
We're not expecting Cardlytics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Currently 2.957% of Cardlytics shares are held by insiders and 90.694% by institutions.
Latest data suggests 489 work at Cardlytics.
Cardlytics's fiscal year ends in December.
Cardlytics's address is: 675 Ponce de Leon Avenue NE, Atlanta, GA, United States, 30308
Cardlytics's international securities identification number is: US14161W1053
Cardlytics's Committee on Uniform Securities Identification Procedures number is: 14161W105
It's as easy to sell Cardlytics as it is to buy! Here's how to sell Cardlytics that you already own.
Open your investment app. If you've got one with desktop access, you can log in online
Go to your portfolio. This should be in the main menu
Find your shares. You may be able to search your portfolio
Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
Sell your Cardlytics shares. Your investment platform will let you know when your shares are sold
Most share dealing providers in the UK will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.
The easiest way to get hold of some Cardlytics shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Cardlytics shares.
If you're investing in a US stock, you'll need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.
Financials
Revenue TTM
$294.9 million
Gross profit TTM
$115.4 million
Return on assets TTM
-7.4%
Return on equity TTM
-102.69%
Profit margin
-164.33%
Book value
$6.9
Market capitalisation
$171.6 million
TTM: trailing 12 months
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
How likely would you be to recommend finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
Advertiser Disclosure
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
